Active immunization with tau epitope in a mouse model of tauopathy induced strong antibody response together with improvement in short memory and pSer396-tau pathology
Abnormal tau hyperphosphorylation and its aggregation into neurofibrillary tangles are a hallmark of tauopathies, neurodegenerative disorders that include Alzheimer's disease (AD). Active and passive Tau-immunotherapy has been proposed as a therapeutic approach to AD with mixed results. One of...
Main Authors: | A. Joly-Amado, H. Davtyan, K. Serraneau, P. Jules, A. Zitnyar, E. Pressman, K. Zagorski, T. Antonyan, A. Hovakimyan, H.J. Paek, M.N. Gordon, D.H. Cribbs, N. Petrovsky, M.G. Agadjanyan, A. Ghochikyan, D. Morgan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-02-01
|
Series: | Neurobiology of Disease |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996119303110 |
Similar Items
-
Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic mice
by: Hayk Davtyan, et al.
Published: (2019-12-01) -
Targeting tauopathy with engineered tau-degrading intrabodies
by: Gilbert Gallardo, et al.
Published: (2019-10-01) -
Glial Tau Pathology in Tauopathies: Functional Consequences
by: Martha A. Kahlson, et al.
Published: (2016-02-01) -
Glial Tau Pathology in Tauopathies: Functional Consequences
by: Martha A. Kahlson, et al.
Published: (2015-01-01) -
Are tau aggregates toxic or protective in tauopathies?
by: Catherine M Cowan, et al.
Published: (2013-08-01)